315 related articles for article (PubMed ID: 22251061)
1. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.
Djupesland PG; Skretting A
J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):280-9. PubMed ID: 22251061
[TBL] [Abstract][Full Text] [Related]
2. Breath actuated device improves delivery to target sites beyond the nasal valve.
Djupesland PG; Skretting A; Winderen M; Holand T
Laryngoscope; 2006 Mar; 116(3):466-72. PubMed ID: 16540911
[TBL] [Abstract][Full Text] [Related]
3. Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.
Moller W; Saba GK; Haussinger K; Becker S; Keller M; Schuschnig U
Rhinology; 2011 Aug; 49(3):286-91. PubMed ID: 21858257
[TBL] [Abstract][Full Text] [Related]
4. A Trans-Nasal Aerosol Delivery Device for Efficient Pulmonary Deposition.
Zeman KL; Balcazar JR; Fuller F; Donn KH; Boucher RC; Bennett WD; Donaldson SH
J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):223-229. PubMed ID: 28157412
[TBL] [Abstract][Full Text] [Related]
5. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.
Möller W; Schuschnig U; Khadem Saba G; Meyer G; Junge-Hülsing B; Keller M; Häussinger K
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):382-8. PubMed ID: 20172385
[TBL] [Abstract][Full Text] [Related]
6. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations.
Al-Ghananeem AM; Sandefer EP; Doll WJ; Page RC; Chang Y; Digenis GA
Int J Pharm; 2008 Jun; 357(1-2):70-6. PubMed ID: 18329197
[TBL] [Abstract][Full Text] [Related]
7. Deposition pattern from a nasal pump spray.
Newman SP; Morén F; Clarke SW
Rhinology; 1987 Jun; 25(2):77-82. PubMed ID: 3616395
[TBL] [Abstract][Full Text] [Related]
8. Topical drug delivery in chronic rhinosinusitis patients before and after sinus surgery using pulsating aerosols.
Möller W; Schuschnig U; Celik G; Münzing W; Bartenstein P; Häussinger K; Kreyling WG; Knoch M; Canis M; Becker S
PLoS One; 2013; 8(9):e74991. PubMed ID: 24040372
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration.
Bacon R; Newman S; Rankin L; Pitcairn G; Whiting R
Int J Pharm; 2012 Jul; 431(1-2):39-44. PubMed ID: 22525081
[TBL] [Abstract][Full Text] [Related]
10. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
[TBL] [Abstract][Full Text] [Related]
11. Deposition pattern of nasal sprays in man.
Newman SP; Morén F; Clarke SW
Rhinology; 1988 Jun; 26(2):111-20. PubMed ID: 3175455
[TBL] [Abstract][Full Text] [Related]
12. Nasal distribution of radioactive drug administered using two dosage forms.
Vidgren P; Vidgren M; Paronen P; Vainio P; Nuutinen J
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():426-32. PubMed ID: 1820917
[TBL] [Abstract][Full Text] [Related]
13. Aerosol Delivery with Two Nebulizers Through High-Flow Nasal Cannula: A Randomized Cross-Over Single-Photon Emission Computed Tomography-Computed Tomography Study.
Dugernier J; Hesse M; Jumetz T; Bialais E; Roeseler J; Depoortere V; Michotte JB; Wittebole X; Ehrmann S; Laterre PF; Jamar F; Reychler G
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):349-358. PubMed ID: 28463044
[TBL] [Abstract][Full Text] [Related]
14. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder.
Obaidi M; Offman E; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2013 Sep; 53(8):1323-33. PubMed ID: 23992438
[TBL] [Abstract][Full Text] [Related]
15. Regional deposition of mometasone furoate nasal spray suspension in humans.
Shah SA; Berger RL; McDermott J; Gupta P; Monteith D; Connor A; Lin W
Allergy Asthma Proc; 2015; 36(1):48-57. PubMed ID: 25562556
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.
Tafaghodi M; Abolghasem Sajadi Tabassi S; Jaafari MR; Zakavi SR; Momen-Nejad M
Int J Pharm; 2004 Aug; 280(1-2):125-35. PubMed ID: 15265553
[TBL] [Abstract][Full Text] [Related]
17. Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients.
Leach CL; Kuehl PJ; Chand R; McDonald JD
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):334-40. PubMed ID: 25671692
[TBL] [Abstract][Full Text] [Related]
18. Bi-directional nasal delivery of aerosols can prevent lung deposition.
Djupesland PG; Skretting A; Winderen M; Holand T
J Aerosol Med; 2004; 17(3):249-59. PubMed ID: 15625817
[TBL] [Abstract][Full Text] [Related]
19. Development and testing of particulate formulations for the nasal delivery of antibodies.
Kaye RS; Purewal TS; Alpar OH
J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic assessment of the oropharyngeal and nasal depositions of fusafungine from a pressurized inhaler and from a novel pump spray device.
Newman SP; Steed KP; Hooper G; Brickwell J
J Pharm Pharmacol; 1995 Oct; 47(10):818-21. PubMed ID: 8583349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
